112566 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Test for non-septic hypovolemic shock
#902Urokinase-Type Plasminogen Activator Protein /Plasminogen Activator Inhibitor Type-1 Protein Selected Reaction Monitoring Assay
#903Compounds and Methods for FRET Based Measurement of Enzyme Activity
#904Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 protease
#905BIOMARKERS
#906ASSAYS AND METHODS USING BIOMARKERS
#907Qualitative and Quantitative Analytical Method for Analyzing the Activity Type of an Enzyme that is Activated by Proteolysis
#908DNA-DAMAGE-INDUCED PROTEOLYSIS
#909IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#910METHODS AND COMPOSITIONS FOR MODULATING PROSTASIN
#911Method for assaying histone methylation enzyme activity
#912USE OF A SUBSTRATE IN A METHOD FOR MEASURING THE ACTIVITY OF AVAILABLE PROTEOLYTIC ENZYMES
#913USE OF A SUBSTRATE IN A METHOD FOR MEASURING THE ACTIVITY OF PROTEOLYTIC ENZYMES
#914In vitro assay for quantifying clostridial neurotoxin activity
#915CELL FREE CD4 QUANTITATION AND METHODS OF USE
#916METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
#917Method for separating peptides and proteins
#918Reporter system for high throughput screening of compounds and uses thereof
#919METHOD FOR THE DETERMINATION OF SEQUENCE VARIANTS OF POLYPEPTIDES
#920Resonance energy transfer assay with synaptobrevin substrate moiety
#921Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases
#922Protease screening methods and proteases identified thereby
#923Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
#924PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY
#925Probe reagent for measurement of proteolytic activity
#926Biomarkers for the detection and screening of down syndrome
#927Methods of measuring cell viability in tissue engineered products
#928MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#929Mutated SUMO isoforms and uses thereof
#930IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA
#931MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#932MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS
#933Method of detecting phytase activity or protease activity
#934Antichlamydial agents
#935AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT PEPTIDYL-DIPEPTIDASE A ACTIVITY
#936METHOD CIRCUIT AND SYSTEM FOR DETECTING A CONNECTION REQUEST WHILE MAINTAINING A LOW POWER MODE
#937USE OF CATHEPSIN H
#938IDENTIFICATION OF MODULATORS OF SERINE PROTEASE INHIBITOR KAZAL AND THEIR USE AS ANTI-CANCER AND ANTI-VIRAL AGENTS
#939SCREENING METHOD FOR SUBSTANCE CAPABLE OF PROMOTING RECOVERY OF SKIN BARRIER FUNCTION TECHNICAL FIELD
#940Methods for identifying inhibitors of botulinum neurotoxins
#941Method for treating pervasive development disorders
#942Methods and apparatus for fractionation-based chemical analyses
#943Immuno-based botulinum toxin serotype A activity assays
#944Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
#945MASP 2, a complement-fixing enzyme, and uses for it
#946Method of regulating the expression level of survival of motor neuron 1
#947ASSAY FOR PCSK9 INHIBITORS
#948Cellular depletion of biomolecular targets
#949Method for treating pervasive development disorders
#950A-FUCOSYLATION DETECTION IN ANTIBODIES
#951Screening strategies for the identification of binders
#952Compositions comprising enzyme-cleavable oxycodone prodrug
#953Compositions comprising enzyme-cleavable oxycodone prodrug
#954METHODS AND DEVICES FOR DETECTING THROMBIN GENERATION
#955Compositions and methods for identifying enzyme and transport protein inhibitors
#956Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
#957METHODS OF TREATING, REDUCING AND INHIBITING THE APPEARANCE OF AGEING IN THE SKIN
#958Methods and kit for protease enzyme assays
#959Method of detecting botulinum neurotoxin and antibodies that neutralize botulinum neurotoxin action
#960MEANS AND METHODS FOR COUNTERACTING POLYQ EXPANSION DISORDERS
#961MRI AND OPTICAL ASSAYS FOR PROTEASES
#962Automated method and system for the analysis of total dietary fiber
#963Electrochemical assay for the detection of enzymes
#964Method for simultaneously determining multiple coagulation proteases
#965Compounds and methods for protease detection
#966Detection and quantification of modified proteins
#967Luminescent live and dead cell assay
#968Enzyme detection device
#969CASPASE-8 AND SKIN DISEASE
#970METHOD FOR THE PREVENTION OR REDUCTION OF HAZE IN BEVERAGES
#971Antibodies and methods of use thereof
#972Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereof
#973Rapid bed-side measurement of neutrophil elastase activity in biological fluids
#974ASSAY TOOLS AND METHODS OF USE
#975Peptidase substrates
#976COMPOSITION FOR ASSAYING GLYCATED PROTEINS
#977Self-immolative probes for enzyme activity detection
#978Peptidase substrates
#979Peptidase substrates
#980Devices for the detection of the presence and/or activity of proteases in biological samples
#981Immuno-based botulinum toxin serotype A activity assays
#982Cleavage sensitive antibodies and methods of use thereof
#983Treatment of pulmonary vascular remodeling with neprilysin
#984METHODS FOR TREATMENT OF BACTERIAL INFECTIONS
#985Compositions and Methods for Diagnosis of Shock
#986MARKED PEPTIDES AND USE THEREOF FOR ASSAYING CIRCULATING IRAP
#987Cyanine dyes
#988Enzyme substrate comprising a functional dye and associated technology and methods
#989Method for treating pervasive development disorders
#990Method for treating pervasive development disorders
#991Methods for early detection of blood disorders
#992Di- and poly-ubiquitin deubiquitinase substrates and uses thereof
#993Method for reducing the appearance of false positive bands in SDS-page analysis of proteolytic digestion of a sample
#994OPTICAL REACTION MEASUREMENT DEVICE AND OPTICAL REACTION MEASUREMENT METHOD
#995Prediction of Memapsin 2 Cleavage Sites
#996SCREENING ASSAYS FOR AGENTS THAT ALTER INHIBITOR OF APOPTOSIS (IAP) PROTEIN REGULATION OF CASPASE ACTIVITY
#997Method for single oxygen atom incorporation into peptides
#998Compositions and methods for identifying enzyme and transport protein inhibitors
#999Prolyl Endopeptidase Probes
#1000Optical detector for use in therapy
#1001Releasable nonvolatile mass-label molecules
#1002Biotinidase assay
#1003Pathology biomarker assay
#1004Substrate peptide sequences for plague plasminogen activator and uses thereof
#1005Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
#1006Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same
#1007Electrochemical assay for the detection of enzymatically active PSA
#1008DIAGNOSTIC METHOD OF SKIN INFLAMMATORY DISEASE
#1009METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#1010Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
#1011Use of DPPIV/seprase as a marker for cancer
#1012METHODS AND SYSTEMS TO DIAGNOSE A CONDITION IN AN INDIVIDUAL
#1013Rapid FRET-based diagnosis of bacterial pathogens
#1014IL-1F5 polypeptides
#1015Method for measuring the activity of cathepsin B after de-inhibition
#1016Diagnosis of infection based on detection of bacterial secreted biomarkers
#1017METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#1018Fructosyl peptide oxidase
#1019Methods and Kits for Detecting Mastitis
#1020Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay
#1021Composition for assaying glycated proteins
#1022Plant Extracts and Dermatological Uses Thereof
#1023Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
#1024Methods and Compositions for Detection of a Pathogen, Disease, Medical Condition, or Biomarker Thereof
#1025Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
#1026SYSTEM FOR DETECTNG PROTEASE
#1027Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor
#1028Treatment of chronic pelvic pain syndrome
#1029Mutant protease biosensors with enhanced detection characteristics
#1030Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue
#1031Preventing and treating sepsis
#1032METHODS AND SYSTEMS TO DETECT AN ACTIVE PROTEASE IN A SAMPLE
#1033Device and method for detection of humidity-compromised urine test strips
#1034Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors
#1035LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
#1036UBIQUITIN PROTEASOME SYSTEM PROFILING FOR DIAGNOSIS OF CHRONIC LIVER DISEASE
#1037Metallopeptide catalysts
#1038Methods of Quantifying Methotrexate Metabolites
#1039MAST CELL CARBOXYPEPTIDASE AS A MARKER FOR ANAPHYLAXIS AND MASTOCYTOSIS
#1040Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof
#1041COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS OF ACTIVE AGENTS AND INHIBITORS THEREOF
#1042COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF
#1043Fluorescent cyclic peptides, preparation method thereof and use of these peptides for measuring the enzymatic activity of a protease enzyme
#1044SYSTEM AND METHOD FOR THE ANALYSIS OF BODILY FLUIDS
#1045TARGETS FOR TREATMENT OF CHLAMYDIAL INFECTIONS
#1046Hepatitis C virus variants
#1047METHOD FOR TESTING ALZHEIMER'S DISEASE BY MEASURING DEGRADATION RATE OF ß-AMYLOID IN BLOOD AND DIAGNOSTIC REAGENT
#1048UBIQUITIN SPECIFIC PROTEASES RESPONSIBLE FOR MCL-1 STABILITY AND USES THEREOF
#1049SCREENING ASSAYS FOR THE IDENTIFICATION OF BACE2 INHIBITORS
#1050Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
#1051Methods for selecting protease resistant polypeptides
#1052Methods of screening an agent for an activity in an isolated eye of a teleost
#1053Methods for the early diagnosis of ovarian cancer
#1054Nanoparticle sensor for measuring protease activity and method for manufacturing the same
#1055Nucleic acid ligand complexes
#1056Methods and compositions for modulating hepatocyte growth factor activator
#1057Method for measuring endotoxin and reagent kit for measuring endotoxin
#1058Screening method for identifying protease secretion-deficient mutants of microorganisms
#1059STERILITY INDICATING BIOLOGICAL COMPOSITIONS, ARTICLES AND METHODS
#1060DETERMINATION OF RENIN-PRORENIN RECEPTOR ACTIVITY
#1061Methods and Compositions for Inhibiting Fungal Infection and Disease
#1062Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertension
#1063Device and methods for liquid crystal-based bioagent detection
#1064Detecting neoplasm
#1065METHOD FOR THE DETECTION OF ENZYMATIC ACTIVITY WITH MAGNETICALLY FUNCTIONALIZED SUBSTRATES
#1066Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
#1067PEPTIDE FOR USE IN SIMULTANEOUS PROTEIN QUANTIFICATION OF METABOLIZING ENZYMES USING MASS SPECTROMETRIC ANALYSIS APPARATUS
#1068FRET-BASED MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE BIOSENSOR AND METHODS FOR USING THE SAME
#1069METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN
#1070METHOD FOR EVALUATING STATUS OF SKIN BARRIER FUNCTION OF NATURAL MOISTURIZING FACTOR USING BLEOMYCIN HYDROLASE ACTIVITY AS INDICATOR
#1071SMALL MOLECULE FLUORESCENT SENSORS FOR DETECTION OF POST-TRANSLATIONALMODIFICATIONS AND PROTEIN INTERACTIONS IN BIOASSAYS
#1072CLEAVAGE OF B-AMYLOID PRECURSOR PROTEIN
#1073Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors
#1074Kit for single oxygen atom incorporation into digested peptides
#1075PLASMA MEMBRANE VESICLES AND METHODS OF MAKING AND USING SAME
#1076Detection and quantitation of full-length thioredoxin (TRX) and truncated thioredoxin (TRX 80) in complex samples
#1077Method for determining treatment of disseminated intravascular coagulation
#1078METHOD FOR IDENTIFICATION OF PROTEASE ACTIVITY INHIBITORS AND ASSAYING THE PRESENCE OF PROTEASE ACTIVITY
#1079"Method for screening compounds comprising the use of picornavirus protease 2A"
#1080USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES
#1081Compositions and Methods for Spatial Separation and Screening of Cells
#1082METHODS, COMPOSITIONS AND COMPOUND ASSAYS FOR INHIBITING AMYLOID-BETA PROTEIN PRODUCTION
#1083METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
#1084Kit for assaying EphA4 processing by gamma-secretase
#1085EphA4 Polypeptide Having a Novel Activity and Use Thereof
#1086Xe biosensors and their use
#1087Soluble notch-based substrates for gamma secretase and methods and compositions for using same
#1088Peptide conjugates and fluorescence detection methods for intracellular caspase assay
#1089METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX
#1090Cathepsin C-based screening methods for identifying modulators of pain
#1091Protease detection
#1092Methods for the early diagnosis of ovarian cancer
#1093HCV NS3-NS4 Protease Resistance Mutants
#1094Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties
#1095Method for the Diagnosis of Leukemia Using Caspase-3
#1096Method for detecting
#1097Detection of degradative enzymes in bodily fluids
#1098METHOD FOR ACCESSING MICROBIAL DIVERSITY
#1099Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents
#1100Method for determining carbohydrate and kit for determining carbohydrate
#1101Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity
#1102FUNCTION AND REGULATION OF ADAMTS-1
#1103Real-time, single-step bioassay using nanoplasmonic resonator with ultra-high sensitivity
#1104Xanthene dyes
#1105Method for detecting or determining abnormal prion protein associated with transmissible spongiform encephalopathy in blood-derived specimen or body fluid-derived specimen
#1106UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
#1107UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR PROLIFERATIVE HEMATOLOGICAL DISORDERS
#1108UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS
#1109Magnetic-nanoparticle conjugates and methods of use
#1110REGULATORS OF MMP-9 AND USES THEROF
#1111Use of a cysteine protease of Plasmodium vivax
#1112Magnetic-nanoparticle conjugates and methods of use
#1113METHOD TO DETECT HEMOLYTIC STREPTOCOCCUS AND OPTOELECTRICALLY DETERMINE RESULTS
#1114Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate
#1115FLUOROGENIC PEPTIDES AND THEIR METHOD OF PRODUCTION
#1116Reaction medium for methicillin-resistant (MRSA) bacteria
#1117Resonance energy transfer assay with cleavage sequence and spacer
#1118Protease assay
#1119Engineered proteases for affinity purification and processing of fusion proteins
#1120METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS
#1121Linked peptides fluorogenic biosensors
#1122Analysis of amino acid copolymer compositions
#1123Methods to identify USP1 deubiquitinating enzyme complex inhibitors
#1124Methods and kits to detect hereditary angioedema type III
#1125Biochemical markers for CVD risk assessment
#1126Protease detection assay
#1127Mass spectrometric endopeptidase assay
#1128Compositions and Methods for Regulating T-Cell Activity
#1129METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIA ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS
#1130MOLECULAR MODIFICATION ASSAYS
#1131CASPASE IMAGING PROBES
#1132Method for detecting a protease
#1133Activated protease indicator
#1134METHOD AND REAGENTS FOR TREATING HEPATIC FIBROSIS AND INFLAMMATION
#1135Caspase inhibitors in the treatment of infection-associated preterm delivery
#1136Methods and Compositions for Enhancing Proteasome Activity
#1137SCREENING METHOD FOR AGENTS SUITABLE FOR THERAPY OF ALZHEIMER'S DISEASE
#1138Methods and compositions for detections and modulating O-glycosylation
#1139Matriptase protein and uses thereof
#1140PEPTIDE CONJUGATES AND FLUORESCENCE DETECTION METHODS FOR INTRACELLULAR CASPASE ASSAY
#1141Methods for the detection of glycated hemoglobin
#1142Cathepsin L mediated diseases and associated methods and products
#1143COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
#1144Method for measuring the activity of proteases
#1145STABILITY TESTING OF ANTIBODIES
#1146Method for determining ACE2 activity
#1147Bioluminescent protease assay
#1148METHOD FOR THE DETECTION OF THE IN-VIVO ACTIVITY OF NEUROTRYPSIN, USE OF THE METHOD AND USE OF THE C-TERMINAL, 22-KDA FRAGMENT OF AGRIN AS BIOMARKER IN DIAGNOSIS AND MONITORING OF NEUROTRYPSIN-RELATED DISTURBANCES
#1149Methods and products for in vivo enzyme profiling
#1150Method for Identifying Modulators of Gamma Secretase or Notch
#1151Bisubstrate fluorescent probe binding to protein kinases
#1152Immuno-based retargeted endopeptidase activity assays
#1153METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#1154Method for determining the presence of an enzyme in a sample
#1155METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#1156Enzyme containing liquid and delivery system for detection of analytes on surfaces
#1157Enzymatic methods and enzymes
#1158AFFINITY CAPTURE OF PEPTIDES BY MICROARRAY AND RELATED METHODS
#1159METHOD AND KIT FOR UNIVERSAL VERIFICATION OF ENZYME ACTIVITY AND PROTEIN DIGESTION
#1160Methods of detecting mastitis by levels of proteasomes
#1161METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION
#1162METHOD OF IDENTIFICATION AND QUANTIFICATION OF PROTEINS, ISOFORMS OF THE ANGIOTENSIN I CONVERTING ENZYME, MOLECULAR GENETIC MARKER BASED ON SAID PROTEINS, USE OF MENTIONED MARKER, ANALYTICAL METHOD FOR DIAGNOSIS, RISK STRATIFICATION, THERAPEUTICAL DECISION IN CARRIERS OF ARTERIAL HYPERTENSION AND RENAL LESION AND KIT FOR USING IN THE DIAGNOSIE
#1163Measurement Of Protease Activity In Post-Mortem Meat Samples
#1164Fibrosis biomarker assay
#1165METHOD FOR TREATING DISEASES RELATED TO MITOCHONDRIAL DYSFUNCTION
#1166Methods for identifying inhibitors of botulinum neurotoxins
#1167Immuno-based botulinum toxin serotype A activity assays
#1168Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies
#1169SCREENING METHOD UTILIZING NOVEL SUBSTRATE C-RET FOR GAMMA-SECRETASE
#1170Imaging probes
#1171Malt1 specific cleavage in assay and screening method
#1172Ligand binding stabilization method for drug target identification
#1173Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
#1174Method of measuring HbA1c
#1175USE OF COAGULATION PROTEINS TO LYSE CLOTS
#1176Crystal structure of the N-terminal domain of angiotensin converting enzyme and uses thereof
#1177METHODS AND USES RELATED TO RHBDL4
#1178Cellular libraries of peptide sequences (CLiPS) and methods of using the same
#1179UTILIZATION OF TACE INHIBITORS FOR THE TREATMENT OF ACNE
#1180METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE FORMULATIONS AND AS VECTORS FOR EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS FOR PROPAGATING VIRUS
#1181Methods For Detection Of Sepsis
#1182METHODS OF QUANTIFYING METHOTREXATE METABOLITES
#1183PROTEOLYTIC RELEASE OF GLYCANS
#1184FRET protease assays for clostridial toxins
#1185Method for quantifying biomolecules conjugated to a nanoparticle
#1186Kinase and ubiquination assays
#1187Compositions and Methods for Modulation of ADAMTS13 Activity
#1188C-terminal domain truncation of mGluR1α by calpain and uses thereof
#1189Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereof
#1190DNA-damage-induced proteolysis
#1191ASSAY METHODS FOR IDENTIFYING AGENTS THAT MODIFY THE ACTIVITY OF NAPE-PLD OR Abh4
#1192ENZYMATIC DIAGNOSTIC TEST FOR SARS AND OTHER VIRAL DISEASES
#1193High-throughput assay for evaluating dipeptidyl peptidase I activity
#1194Methods and kits for determining von willebrand factor activity in the absence of ristocetin
#1195Cyanine dyes
#1196Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#1197METHOD FOR DETECTING THE BINDING BETWEEN MDM2 AND THE PROTEASOME
#1198Method for separation and characterization of microorganisms using identifier agents
#1199Gold nanoparticle based protease imaging probes and use thereof
#1200Separation device for use in the separation, characterization and/or identification of microorganisms